Polyvinylpyrrolidone (PVP) is a hydrophilic polymer widely employed as a carrier in the
pharmaceutical, biomedical, and nutraceutical fields. Up to now, several PVP-based …

The potential of the mucoadhesive film technology is hard to ignore, owing to perceived
superior patient acceptability versus buccal tablets, and significant therapeutic opportunities …

Hydroxypropylmethylcellulose (HPMC), also known as Hypromellose, is a traditional
pharmaceutical excipient widely exploited in oral sustained drug release matrix systems …

Despite the burgeoning interest in three-dimensional (3D) printing for the manufacture of
customizable oral dosage formulations, a US Food and Drug Administration–approved …

Over the recent past, many of the research groups are focusing their research on this
technology. Amongst the plethora of avenues explored for rapid drug releasing products …

Extended-release gastrointestinal (GI) luminal delivery substantially increases the ease of
administration of drugs and consequently the adherence to therapeutic regimens. However …

The buccal route of administration has a number of advantages including bypassing the
gastrointestinal tract and the hepatic first pass effect. Mucoadhesive films are retentive …

Extensive research on transmucosal drug delivery in the past few decades has resulted in
the clinical application of several drug molecules through the buccal route. Interestingly …

Lornoxicam (LRX) is a potent nonsteroidal anti-inflammatory drug (NSAID) used extensively
to manage pain and inflammatory conditions. However, the drug possesses poor aqueous …

Mucosa of the buccal cavity is considered a convenient and easily accessible site for the
administration of drugs intended for both local and systemic delivery. Aiming to optimize the …